This comprehensive diagnostic suite of immunohistochemistry (IHC) assays includes the application and interpretation of results from 12 different immunohistochemical markers on fixed tissue samples. This extensive suite aims to resolve complex diagnostic challenges by providing a complete "immunological fingerprint" of the tumor, contributing to definitive classification, evaluation of biological behavior, and simultaneous identification of potential therapeutic targets.